Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis

被引:7
作者
Xia, Qianjing [1 ]
Lee, Myung Hee [2 ]
Walsh, Kathleen F. [2 ,3 ]
McAulay, Kathrine [2 ,4 ]
Bean, James M. [5 ]
Fitzgerald, Daniel W. [2 ,3 ,6 ]
Dupnik, Kathryn M. [2 ,3 ]
Johnson, Warren D. [2 ,3 ,6 ]
Pape, Jean W. [2 ,6 ]
Rhee, Kyu Y. [2 ,3 ,4 ]
Isa, Flonza [3 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] Weill Cornell Med, Ctr Global Hlth, New York, NY 10065 USA
[3] Weill Cornell Med, Dept Med, 1300 York Ave,Room A-421, New York, NY 10065 USA
[4] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Ctr GHESKIO, Port Au Prince, Haiti
关键词
N-1; N-12-DIACETYLSPERMINE; N-8-DIACETYLSPERMIDINE; DIAGNOSIS; SYSTEMS; HOST; TIME;
D O I
10.1172/jci.insight.136301
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND. Control of the tuberculosis (TB) pandemic remains hindered in part by a lack of simple and accurate measures of treatment efficacy, as current gold standard markers rely on sputum-based assays that are slow and challenging to implement. However, previous work identified urinary N-1, N-12-diacetylspermine (DiAcSpm), neopterin, hydroxykynurenine, N-acetylhexosamine, ureidopropionic acid, sialic acid, and mass-to-charge ratio (m/z) 241.0903 as potential biomarkers of active pulmonary TB (ATB). Here, we evaluated their ability to serve as biomarkers of TB treatment response and mycobacterial load. METHODS. We analyzed urine samples prospectively collected from 2 cohorts with ATB. A total of 34 study participants from African countries treated with first-line TB therapy rifampin, isoniazid, pyrazinamide, and ethambutol (HRZE) were followed for 1 year, and 35 participants from Haiti treated with either HRZE or an experimental drug were followed for 14 days. Blinded samples were analyzed by untargeted HPLC-coupled high-resolution TOF-mass spectrometry. RESULTS. Urinary levels of all 7 molecules significantly decreased by week 26 of successful treatment (P = 0.01 to P < 0.0001) and positively correlated with sputum mycobacterial load (P < 0.0001). Urinary DiAcSpm levels decreased significantly in participants treated with HRZE as early as 14 days (P < 0.0001) but remained unchanged in cases of ineffective therapy (P = 0.14). CONCLUSION. Urinary DiAcSpm, neopterin, hydroxykynurenine, N-acetylhexosamine, ureidopropionic acid, sialic acid, and m/z 241.0903 reductions correlated with successful anti-TB treatment and sputum mycobacterial load. Urinary DiAcSpm levels exhibited reductions capable of differentiating treatment success from failure as early as 2 weeks after the initiation of chemotherapy, advocating its further development as a potentially simple, noninvasive biomarker for assessing treatment response and bacterial load.
引用
收藏
页数:16
相关论文
共 48 条
  • [1] Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response (vol 125, pg 1827, 2015)
    Adekambi, Toidi
    Ibegbu, Chris C.
    Cagle, Stephanie
    Kalokhe, Ameeta S.
    Wang, Yun F.
    Hu, Yijuan
    Day, Cheryl L.
    Ray, Susan M.
    Rengarajan, Jyothi
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09) : 3723 - 3723
  • [2] Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients
    Adu-Gyamfi, Clement G.
    Snyman, Tracy
    Hoflmann, Christopher J.
    Martinson, Neil A.
    Chaisson, Richard E.
    George, Jaya A.
    Suchard, Melinda S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2017, 65 (08) : 1356 - 1363
  • [3] AHMAD P, 1985, Indian Pediatrics, V22, P191
  • [4] Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis
    Alene, Kefyalew Addis
    Viney, Kerri
    Yi, Hengzhong
    McBryde, Emma S.
    Yang, Kunyun
    Bai, Liqiong
    Gray, Darren J.
    Xu, Zuhui
    Clements, Archie C. A.
    [J]. PLOS ONE, 2018, 13 (05):
  • [5] Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure
    Ambreen, Atiqa
    Jamil, Muhammad
    Rahman, Mohammad Aqeel Ur
    Mustafa, Tehmina
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (01) : 923
  • [6] [Anonymous], GLOB TUB REP 2018
  • [7] Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
    Balaji, V.
    Daley, Peter
    Anand, Alok Azad
    Sudarsanam, Thambu
    Michael, Joy Sarojini
    Sahni, Rani Diana
    Chordia, Poorvi
    George, Ige Abraham
    Thomas, Kurien
    Ganesh, Alka
    John, K. R.
    Mathai, Dilip
    [J]. PLOS ONE, 2010, 5 (03):
  • [8] Pleural fluid neopterin levels in tuberculous pleurisy
    Cok, Gursel
    Parildar, Zuhal
    Basol, Gunes
    Kabaroglu, Ceyda
    Bayindir, Ulku
    Habif, Sara
    Bayindir, Ova
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (12) : 876 - 880
  • [9] Urine Antigen Tests for the Diagnosis of Respiratory Infections Legionellosis, Histoplasmosis, Pneumococcal Pneumonia
    Couturier, Marc Roger
    Graf, Erin H.
    Griffin, Allen T.
    [J]. CLINICS IN LABORATORY MEDICINE, 2014, 34 (02) : 219 - +
  • [10] Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens
    Diacon, Andreas H.
    van der Merwe, Lize
    Demers, Anne-Marie
    von Groote-Bidlingmaier, Florian
    Venter, Amour
    Donald, Peter R.
    [J]. TUBERCULOSIS, 2014, 94 (02) : 148 - 151